Drug Shortage Report for PERSANTINE
| Report ID | 181380 |
| Drug Identification Number | 00637734 |
| Brand name | PERSANTINE |
| Common or Proper name | Persantine |
| Company Name | GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE |
| Market Status | MARKETED |
| Active Ingredient(s) | DIPYRIDAMOLE |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 5´s |
| ATC code | B01AC |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-02-01 |
| Actual start date | |
| Estimated end date | 2024-02-01 |
| Actual end date | 2024-02-08 |
| Shortage status | Resolved |
| Updated date | 2024-02-28 |
| Company comments | Shortage resolved, Persantin is available in the market, manufacture issues resolved |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | ARABELLASTR 17 MUNICH, -- GERMANY 81925 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2024-02-28 | French | Compare |
| v6 | 2024-02-28 | French | Compare |
| v5 | 2024-02-28 | English | Compare |
| v4 | 2023-07-18 | English | Compare |
| v3 | 2023-02-02 | English | Compare |
| v2 | 2023-01-18 | French | Compare |
| v1 | 2023-01-18 | English | Compare |
Showing 1 to 7 of 7